Evolution of MHC-based technologies used for detection of antigen-responsive T cells

Cancer Immunology, Immunotherapy

Volumn 66, Issue 5, 2017, Pages 657-666

  Bentzen, Amalie Kai ^a   Hadrup, Sine Reker ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Antigen specificity; DNA barcode labeled MHC multimers; MHC class I; MHC multimer; T cell receptor

Indexed keywords

ANTIGEN; HLA B27 ANTIGEN; POLYMER; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN DETECTION; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DNA BARCODING; EVOLUTION; HUMAN; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASM; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; IMMUNOLOGY; T LYMPHOCYTE;

ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 85015637323     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-017-1971-5     Document Type: Review

References (46)

1. Altman JD, Moss PA, Goulder PJ et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94–96. doi:10.1126/science.274.5284.94
2. Bakker AH, Schumacher TNM (2005) MHC multimer technology: current status and future prospects. Curr Opin Immunol 17:428–433. doi:10.1016/j.coi.2005.06.008
3. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429–3433
4. Toebes M, Coccoris M, Bins A et al (2006) Design and use of conditional MHC class I ligands. Nat Med 12:246–251. doi:10.1038/nm1360
5. Bakker AH, Hoppes R, Linnemann C et al (2008) Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc Natl Acad Sci USA 105:3825–3830. doi:10.1073/pnas.0709717105
6. Rodenko B, Toebes M, Hadrup SR et al (2006) Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat Protoc 1:1120–1132. doi:10.1038/nprot.2006.121
7. Frøsig TM, Yap J, Seremet T et al (2015) Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05. Cytom Part A 87:967–975. doi:10.1002/cyto.a.22689
8. Chang CXL, Tan AT, Or MY et al (2013) Conditional ligands for Asian HLA variants facilitate the definition of CD8 + T-cell responses in acute and chronic viral diseases. Eur J Immunol 43:1109–1120. doi:10.1002/eji.201243088
9. Leisner C, Loeth N, Lamberth K et al (2008) One-pot, mix-and-read peptide-MHC tetramers. PLoS One 3:e1678. doi:10.1371/journal.pone.0001678
10. Saini SK, Ostermeir K, Ramnarayan VR et al (2013) Dipeptides promote folding and peptide binding of MHC class I molecules. Proc Natl Acad Sci USA 110:15383–15388. doi:10.1073/pnas.1308672110
11. Saini SK, Schuster H, Ramnarayan VR et al (2015) Dipeptides catalyze rapid peptide exchange on MHC class I molecules. Proc Natl Acad Sci USA 112:202–207. doi:10.1073/pnas.1418690112
12. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470
13. MacBeath G, Schreiber SL (2000) Printing proteins as microarrays for high-throughput function determination. Science 289:1760–1763
14. Soen Y, Chen DS, Kraft DL et al (2003) Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 1:E65. doi:10.1371/journal.pbio.0000065
15. Stone JD, Demkowicz WE, Stern LJ (2005) HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. Proc Natl Acad Sci USA 102:3744–3749. doi:10.1073/pnas.0407019102
16. Chen DS, Soen Y, Stuge TB et al (2005) Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med 2:e265. doi:10.1371/journal.pmed.0020265
17. Deviren G, Gupta K, Paulaitis ME, Schneck JP (2007) Detection of antigen-specific T cells on p/MHC microarrays. J Mol Recognit 20:32–38. doi:10.1002/jmr.805
18. Kwong GA, Radu CG, Hwang K et al (2009) Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells. J Am Chem Soc 131:9695–9703. doi:10.1021/ja9006707
19. Brooks SE, Bonney SA, Lee C et al (2015) Application of the pMHC array to characterise tumour antigen specific T cell populations in leukaemia patients at disease diagnosis. PLoS One 10:e0140483. doi:10.1371/journal.pone.0140483
20. Hadrup SR, Bakker AH, Shu CJ et al (2009) Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods. doi:10.1038/nmeth.1345
21. Newell EW, Klein LO, Yu W, Davis MM (2009) Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Methods 6:497–499. doi:10.1038/nmeth.1344
22. Ornatsky OI, Baranov VI, Bandura DR et al (2006) Messenger RNA detection in leukemia cell lines by novel metal-tagged in situ hybridization using inductively coupled plasma mass spectrometry. Transl Oncogenomics 1:1–9
23. Bandura DR, Baranov VI, Ornatsky OI et al (2009) Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 81:6813–6822. doi:10.1021/ac901049w
24. Bendall SC, Simonds EF, Qiu P et al (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332:687–696. doi:10.1126/science.1198704
25. Newell EW, Sigal N, Nair N et al (2013) Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol. doi:10.1038/nbt.2593
26. Spitzer MH, Nolan GP (2016) Mass cytometry: single cells, many features. Cell 165:780–791. doi:10.1016/j.cell.2016.04.019
27. Klinger M, Pepin F, Wilkins J et al (2015) Multiplex identification of antigen-specific T Cell receptors using a combination of immune assays and immune receptor sequencing. PLoS One 10:e0141561. doi:10.1371/journal.pone.0141561
28. Bentzen AK, Marquard AM, Lyngaa R et al (2016) Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol 34:1037–1045. doi:10.1038/nbt.3662
29. Xu Q, Schlabach MR, Hannon GJ, Elledge SJ (2009) Design of 240,000 orthogonal 25mer DNA barcode probes. Proc Natl Acad Sci USA 106:2289–2294. doi:10.1073/pnas.0812506106
30. Kivioja T, Vähärautio A, Karlsson K et al (2011) Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods 9:72–74. doi:10.1038/nmeth.1778
31. Andersen RS, Thrue CA, Junker N et al (2012) Dissection of T-cell antigen specificity in human melanoma. Cancer Res 72:1642–1650. doi:10.1158/0008-5472.CAN-11-2614
32. McGranahan N, Furness AJS, Rosenthal R et al (2016) Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351:1463–1469. doi:10.1126/science.aaf1490
33. + T cells in human melanoma. Nat Med 21:81–85. doi:10.1038/nm.3773
34. Kreiter S, Vormehr M, van de Roemer N et al (2015) Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520:692–696. doi:10.1038/nature14426
35. Roep BO, Peakman M (2011) Diabetogenic T lymphocytes in human type 1 diabetes. Curr Opin Immunol 23:746–753. doi:10.1016/j.coi.2011.10.001
36. + T lymphocytes as pathogenic effectors and therapeutic targets. Lancet Neurol 15:198–209. doi:10.1016/S1474-4422(15)00334-8
37. Crawford F, Kozono H, White J et al (1998) Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675–682
38. Vollers SS, Stern LJ (2008) Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 123:305–313. doi:10.1111/j.1365-2567.2007.02801.x
39. Braendstrup P, Justesen S, Osterbye T et al (2013) MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides. PLoS One 8:e73648. doi:10.1371/journal.pone.0073648
40. Day CL, Seth NP, Lucas M et al (2003) Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Investig 112:831–842. doi:10.1172/JCI18509
41. Rudensky AYu, Preston-Hurlburt P, Hong SC et al (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622–627. doi:10.1038/353622a0
42. Cole DK, Pumphrey NJ, Boulter JM et al (2007) Human TCR-binding affinity is governed by MHC class restriction. J Immunol 178:5727–5734. doi:10.4049/jimmunol.178.9.5727
43. Andreatta M, Karosiene E, Rasmussen M et al (2015) Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics 67:641–650. doi:10.1007/s00251-015-0873-y
44. Snyder A, Makarov V, Merghoub T et al (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189–2199. doi:10.1056/NEJMoa1406498
45. Rizvi NA, Hellmann MD, Snyder A et al (2015) Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348:124–128. doi:10.1126/science.aaa1348
46. Hugo W, Zaretsky JM, Sun L et al (2016) Genomic and Transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165:35–44. doi:10.1016/j.cell.2016.02.065